Etonogestrel implant in adolescents: Evaluation of clinical aspects

Contraception

Volumn 83, Issue 4, 2011, Pages 336-339

  Guazzelli, Cristina A F ^a   De Queiroz, Flaviano Teixeira ^a   Barbieri, Marcia ^a   Torloni, Maria Regina ^a   De Araujo, Fabio Fernando ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescent; Blood pressure; Contraceptive; Etonogestrel; Metabolism; Postpartum; Weight

Indexed keywords

ETONOGESTREL;

ADOLESCENT; ARTICLE; BODY MASS; CLINICAL TRIAL; DELIVERY; DIASTOLIC BLOOD PRESSURE; FAMILY PLANNING; FEMALE; FEMALE CONTRACEPTIVE DEVICE; FOLLOW UP; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; IMPLANT; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADOLESCENT; BLOOD PRESSURE; BODY WEIGHT; CHI-SQUARE DISTRIBUTION; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DRUG IMPLANTS; FEMALE; HUMANS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 79952573303     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.08.004     Document Type: Article

References (23)

1. Paranjothy S, Broughton H, Adappa R, Fone D. Teenage pregnancy: who suffers? Arch Dis Child 2009;94:239-45.
2. Crittenden CP, Boris NW, Rice JC, Taylor CA, Olds DL. The role of mental health factors, behavioral factors, and past experiences in the prediction of rapid repeat pregnancy in adolescence. J Adolesc Health 2009;44:25-32.
3. Tyrer LB. Oral contraceptive for the adolescent. J Reprod Med 1984; 29(7 Suppl):551-9.
4. Mestad RE, Kenerson J, Peipert JF. Reversible contraception update: the importance of long-acting reversible contraception. Postgrad Med 2009;121:18-25.
5. World Health Organization. Medical eligibility criteria for contraceptive use. Reproductive health and research. 4th ed. Geneva: WHO; 2008.
6. Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol 2007;50:907-17. (Pubitemid 350059287)
7. Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008;13(Suppl 1):4-12. (Pubitemid 351364455)
8. Hohmann H. Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive. Patient Prefer Adherence 2009;3:205-11.
9. Arribas-Mir L, Rueda-Lozano D, Agrela-Cardona M, Cedeño-Benavides T, Olvera-Porcel C, Bueno-Cavanillas A. Insertion and 3- year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain. Contraception 2009; 80:457-62.
10. Kuczmarski RJ, Ogdem CL, Grummer-Strawn LM, et al. CDC Growth charts: United States. Adv Data 2000;314:1-27.
11. Altman D. Practical statistics for medical research. London (England): Chapman & Hall; 1991, pp. 250.
12. Berlofi LM, Alkmin ELC, Barbieri M, Guazzelli CAF, Araújo FF. The effectiveness of an educational family planning program in preventing the recurrence of teen pregnancy. Acta Paul Enferm 2006; 19:196-200.
13. Guazzelli CA, de Queiroz FT, Barbieri M, Torloni MR, de Araujo FF. Etonogestrel implant in adolescents: bleeding pattern, efficacy and discontinuation rate. Contraception 2010;82(3):256-9.
14. Harvey C, Seib C, Lucke J. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. Contraception 2009;80:527-32.
15. Polaneczky M, Slap G, Forke C, Rappaport BS, Sondheimer S. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Méd 1994;331:1201-6. (Pubitemid 24331339)
16. Simon CS, Kelly L, Singer D. Preventing repeat adolescent pregnancies with early adoption contraceptive implant. Fam Plann Perspec 1999;31:88-93. (Pubitemid 29202642)
17. Funk S, Miller MM, Mishell Jr DR, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319-26. (Pubitemid 40602307)
18. Macgregor EA. Menstrual migraine: a clinical review. J Fam Plann Reprod Health Care 2007;33:36-47.
19. Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Brit J Obstet Gynaecol 1995;102: 153-9.
20. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. Contraception 1998;57:315-24.
21. Booranabunyat S, Taneepanichskul S. Implanon use in Thai women above the age of 35 years. Contraception 2004;69:489-91. (Pubitemid 38638750)
22. Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 2009;80: 519-26.
23. Stevens-Simon C, Kelly I, Kulick R. A village would be nice but... it takes a long-acting contraceptive to prevent repeat adolescent pregnancies. Am J Prev Med 2001;21:60-5. (Pubitemid 32552008)